|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
005 |
20230526151316.0 |
008 |
140903s2016 moua b 001 0 eng d |
010 |
|
|
|a 2014035140
|
011 |
|
|
|a BIB MATCHES WORLDCAT
|
020 |
|
|
|a 0323321909
|q paperback (alk. paper)
|
020 |
|
|
|a 9780323321907
|q paperback (alk. paper)
|
035 |
|
|
|a (OCoLC)890310283
|
040 |
|
|
|a DNLM/DLC
|b eng
|e rda
|c DLC
|d NLM
|d YDXCP
|d BTCTA
|d LTSCA
|d VAM
|d MMU
|d OCLCF
|d OCLCO
|d ATU
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RM301
|b .P457 2016
|
082 |
0 |
0 |
|a 615.1
|2 23
|
100 |
1 |
|
|a Burchum, Jacqueline Rosenjack,
|e author.
|9 827190
|
245 |
1 |
0 |
|a Lehne's pharmacology for nursing care /
|c Jacqueline Rosenjack Burchum, DNSc, FNP-BC, CNE, Associate Professor, College of Nursing, Department of Advanced Practice and Doctoral Studies, University of Tennessee Health Science Center, Memphis, Tennessee, Laura D. Rosenthal, RN, DNP, ACNP-BC, Assistant Professor, College of Nursing, Assistant Professor, School of Medicine, University of Colorado, Anschutz Medical Campus, Denver, Colorado ; in consultation with Beth Outland Jones, PharmD, Clinical Pharmacist, Missouri Baptist Medical Center, St. Louis, Missouri, Joshua J. Neumiller, PharmD, CDE, FASCP, Assistant Professor of Pharmacotherapy, Washington State University, Spokane, Washington.
|
246 |
1 |
|
|a Pharmacology for nursing care
|
250 |
|
|
|a 9th edition.
|
264 |
|
1 |
|a St. Louis, Missouri :
|b Elsevier/Saunders,
|c [2016]
|
264 |
|
4 |
|c ©2016
|
300 |
|
|
|a x, 1414 pages :
|b illustrations ;
|c 28 cm
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
500 |
|
|
|a Preceded by Pharmacology for nursing care / Richard A. Lehne ; in consultation with Linda A. Moore, Leanna J. Crosby, Diane B. Hamilton. 8th ed. c2013.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Unit I. Introduction -- Unit II. Basic Principles Of Pharmacology -- Unit III. Drug Therapy Across The Life Span -- Unit IV. Peripheral Nervous System Drugs -- Unit V. Central Nervous System Drugs -- Unit VI. Drugs That Affect Fluid And Electrolyte Balance -- Unit VII. Drugs That Affect The Heart, Blood Vessels,and Blood -- Unit VIII. Drugs For Endocrine Disorders -- Unit IX. Women's Health -- Unit X. Men's Health -- Unit XI. Anti-Inflammatory, Antiallergic,and Immunologic Drugs -- Unit XII. Drugs For Bone And Joint Disorders -- Unit XIII. Respiratory Tract Drugs -- Unit XIV. Gastrointestinal Drugs -- Unit XV. Nutrition -- Unit XVI. Chemotherapy Of Infectious Diseases -- Unit XVII. Chemotherapy Of Parasitic Diseases -- Unit XVIII. Cancer Chemotherapy -- Unit XIX. Miscellaneous Drugs And Therapies -- Unit XX. Toxicology -- --
|
505 |
0 |
0 |
|g Unit I.
|t Introduction --
|g 1.
|t Orientation to Pharmacology --
|g 2.
|t Application of Pharmacology in Nursing Practice --
|g 3.
|t Drug Regulation, Development, Names, and Information -- --
|g Unit II.
|t Basic Principles Of Pharmacology --
|g 4.
|t Pharmacokinetics --
|g 5.
|t Pharmacodynamics --
|g 6.
|t Drug Interactions --
|g 7.
|t Adverse Drug Reactions and Medication Errors --
|g 8.
|t Individual Variation in Drug Responses -- --
|g Unit III.
|t Drug Therapy Across The Life Span --
|g 9.
|t Drug Therapy During Pregnancy and Breast-Feeding --
|g 10.
|t Drug Therapy in Pediatric Patients --
|g 11.
|t Drug Therapy in Geriatric Patients -- --
|g Unit IV.
|t Peripheral Nervous System Drugs --
|g 12.
|t Basic Principles of Neuropharmacology --
|g 13.
|t Physiology of the Peripheral Nervous System --
|g 14.
|t Muscarinic Agonists and Antagonists --
|g 15.
|t Cholinesterase Inhibitors and Their Use in Myasthenia Gravis --
|g 16.
|t Drugs That Block Nicotinic Cholinergic Transmission: Neuromuscular Blocking Agents --
|g 17.
|t Adrenergic Agonists --
|g 18.
|t Adrenergic Antagonists --
|g 19.
|t Indirect-Acting Antiadrenergic Agents -- --
|g Unit V.
|t Central Nervous System Drugs --
|g 20.
|t Introduction to Central Nervous System Pharmacology --
|g 21.
|t Drugs for Parkinson's Disease --
|g 22.
|t Drugs for Alzheimer's Disease --
|g 23.
|t Drugs for Multiple Sclerosis --
|g 24.
|t Drugs for Epilepsy --
|g 25.
|t Drugs for Muscle Spasm and Spasticity --
|g 26.
|t Local Anesthetics --
|g 27.
|t General Anesthetics --
|g 28.
|t Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics --
|g 29.
|t Pain Management in Patients with Cancer --
|g 30.
|t Drugs for Headache --
|g 31.
|t Antipsychotic Agents and Their Use in Schizophrenia --
|g 32.
|t Antidepressants --
|g 33.
|t Drugs for Bipolar Disorder --
|g 34.
|t Sedative-Hypnotic Drugs --
|g 35.
|t Management of Anxiety Disorders --
|g 36.
|t Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder --
|g 37.
|t Drug Abuse I: Basic Considerations --
|g 38.
|t Drug Abuse II: Alcohol --
|g 39.
|t Drug Abuse III: Nicotine and Smoking --
|g 40.
|t Drug Abuse IV: Major Drugs of Abuse Other Than Alcohol and Nicotine -- --
|g Unit VI.
|t Drugs That Affect Fluid And Electrolyte Balance --
|g 41.
|t Diuretics --
|g 42.
|t Agents Affecting the Volume and Ion Content of Body Fluids -- --
|g Unit VII.
|t Drugs That Affect The Heart, Blood Vessels,and Blood --
|g 43.
|t Review of Hemodynamics --
|g 44.
|t Drugs Acting on the Renin-Angiotensin-Aldosterone System --
|g 45.
|t Calcium Channel Blockers --
|g 46.
|t Vasodilators --
|g 47.
|t Drugs for Hypertension --
|g 48.
|t Drugs for Heart Failure --
|g 49.
|t Antidysrhythmic Drugs --
|g 50.
|t Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels --
|g 51.
|t Drugs for Angina Pectoris --
|g 52.
|t Anticoagulant, Antiplatelet, and Thrombolytic Drugs --
|
505 |
0 |
0 |
|g 53.
|t Management of ST-Elevation Myocardial Infarction --
|g 54.
|t Drugs for Hemophilia --
|g 55.
|t Drugs for Deficiency Anemias --
|g 56.
|t Hematopoietic Agents -- --
|g Unit VIII.
|t Drugs For Endocrine Disorders --
|g 57.
|t Drugs for Diabetes Mellitus --
|g 58.
|t Drugs for Thyroid Disorders --
|g 59.
|t Drugs Related to Hypothalamic and Pituitary Function --
|g 60.
|t Drugs for Disorders of the Adrenal Cortex -- --
|g Unit IX.
|t Women's Health --
|g 61.
|t Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications --
|g 62.
|t Birth Control --
|g 63.
|t Drug Therapy of Infertility --
|g 64.
|t Drugs That Affect Uterine Function -- --
|g Unit X.
|t Men's Health --
|g 65.
|t Androgens --
|g 66.
|t Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia -- --
|g Unit XI.
|t Anti-Inflammatory, Antiallergic,and Immunologic Drugs --
|g 67.
|t Review of the Immune System --
|g 68.
|t Childhood Immunization --
|g 69.
|t Immunosuppressants --
|g 70.
|t Antihistamines --
|g 71.
|t Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen --
|g 72.
|t Glucocorticoids in Nonendocrine Disorders -- --
|g Unit XII.
|t Drugs For Bone And Joint Disorders --
|g 73.
|t Drug Therapy of Rheumatoid Arthritis --
|g 74.
|t Drug Therapy of Gout --
|g 75.
|t Drugs Affecting Calcium Levels and Bone Mineralization -- --
|g Unit XIII.
|t Respiratory Tract Drugs --
|g 76.
|t Drugs for Asthma and Chronic Obstructive Pulmonary Disease --
|g 77.
|t Drugs for Allergic Rhinitis, Cough, and Colds -- --
|g Unit XIV.
|t Gastrointestinal Drugs --
|g 78.
|t Drugs for Peptic Ulcer Disease --
|g 79.
|t Laxatives --
|g 80.
|t Other Gastrointestinal Drugs -- --
|g Unit XV.
|t Nutrition --
|g 81.
|t Vitamins --
|g 82.
|t Drugs for Weight Loss -- --
|g Unit XVI.
|t Chemotherapy Of Infectious Diseases --
|g 83.
|t Basic Principles of Antimicrobial Therapy --
|g 84.
|t Drugs That Weaken the Bacterial Cell Wall I: Penicillins --
|g 85.
|t Drugs That Weaken the Bacterial Cell Wall II: Cephalosporins, Carbapenems, Vancomycin, Telavancin, Aztreonam, Teicoplanin, and Fosfomycin --
|g 86.
|t Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others --
|g 87.
|t Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis --
|g 88.
|t Sulfonamides and Trimethoprim --
|g 89.
|t Drug Therapy of Urinary Tract Infections --
|g 90.
|t Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infection --
|g 91.
|t Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole, Daptomycin, Rifampin, Rifaximin, Bacitracin, and Polymyxins --
|g 92.
|t Antifungal Agents --
|g 93.
|t Antiviral Agents I: Drugs for Non-HIV Viral Infections --
|g 94.
|t Antiviral Agents II: Drugs for HIV Infection and Related Opportunistic Infections --
|g 95.
|t Drug Therapy of Sexually Transmitted Diseases --
|g 96.
|t Antiseptics and Disinfectants -- --
|g Unit XVII.
|t Chemotherapy Of Parasitic Diseases --
|g 97.
|t Anthelmintics --
|g 98.
|t Antiprotozoal Drugs I: Antimalarial Agents --
|g 99.
|t Antiprotozoal Drugs II: Miscellaneous Agents --
|g 100.
|t Ectoparasiticides -- --
|g Unit XVIII.
|t Cancer Chemotherapy --
|g 101.
|t Basic Principles of Cancer Chemotherapy --
|g 102.
|t Anticancer Drugs I: Cytotoxic Agents --
|g 103.
|t Anticancer Drugs II: Hormonal Agents, Targeted Drugs, and Other Noncytotoxic Anticancer Drugs -- --
|g Unit XIX.
|t Miscellaneous Drugs And Therapies --
|g 104.
|t Drugs for the Eye --
|g 105.
|t Drugs for the Skin --
|g 106.
|t Drugs for the Ear --
|g 107.
|t Additional Noteworthy Drugs --
|g 108.
|t Complementary and Alternative Therapy -- --
|g Unit XX.
|t Toxicology --
|g 109.
|t Management of Poisoning --
|g 110.
|t Potential Weapons of Biologic, Radiologic, and Chemical Terrorism.
|
650 |
|
0 |
|a Pharmacology.
|9 345436
|
650 |
|
0 |
|a Nursing.
|9 321532
|
650 |
|
0 |
|a Chemotherapy.
|9 315208
|
650 |
|
2 |
|a Pharmaceutical Preparations
|9 513764
|
700 |
1 |
|
|a Rosenthal, Laura D.
|e author.
|9 827193
|
700 |
1 |
|
|a Jones, Beth Outland,
|e consultant.
|9 827195
|
700 |
1 |
|
|a Neumiller, Joshua J.,
|e consultant.
|9 827199
|
700 |
1 |
|
|i Based on (expression):
|a Lehne, Richard A.,
|d 1943-
|t Pharmacology for nursing care.
|s 8th ed.
|
907 |
|
|
|a .b14163123
|b 21-05-21
|c 28-10-15
|
942 |
|
|
|c B
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A550768B
|j 0
|l smain
|o -
|p $109.22
|q -
|r -
|s -
|t 0
|u 1
|v 0
|w 1
|x 0
|y .i13436958
|z 29-10-15
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A550769B
|j 0
|l nmain
|n 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons
|o z
|p $109.22
|q -
|r -
|s -
|t 0
|u 3
|v 5
|w 0
|x 3
|y .i1343696x
|z 29-10-15
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A550770B
|j 0
|l nmain
|n 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons
|o z
|p $109.22
|q -
|r -
|s -
|t 0
|u 0
|v 0
|w 0
|x 0
|y .i13436971
|z 29-10-15
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A550771B
|j 0
|l nmain
|o -
|p $109.22
|q -
|r -
|s -
|t 0
|u 2
|v 0
|w 0
|x 3
|y .i13436983
|z 29-10-15
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A550772B
|j 0
|l nmain
|n 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons
|o z
|p $109.22
|q -
|r -
|s -
|t 0
|u 3
|v 5
|w 0
|x 2
|y .i13437008
|z 29-10-15
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A556228B
|j 0
|l nmain
|n 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons
|o z
|p $191.14
|q -
|r -
|s -
|t 0
|u 2
|v 3
|w 0
|x 2
|y .i13443690
|z 29-10-15
|
945 |
|
|
|a 615.1 BUR
|g 1
|i A556213B
|j 0
|l smain
|n 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons
|o z
|p $214.30
|q -
|r -
|s -
|t 0
|u 4
|v 2
|w 0
|x 4
|y .i13445455
|z 29-10-15
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367184
|a S
|b S
|c smain
|d 2015-10-29
|g 109.22
|i i13436958
|l 1
|m 0
|o 615.1 BUR
|p A550768B
|r 2024-01-16 00:00:00
|s 2021-07-23
|t 1
|v 109.22
|w 2021-10-31
|x 03-12-15 ON RESERVE FOR 527188;31-01-20 OFF RESERVE FOR 527188. CIRCED 0 TIMES - AS REMOVED FROM SL AS REQUESTED BY DA |
|y B
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367185
|a N
|b N
|c nmain
|d 2015-10-29
|g 109.22
|i i1343696x
|l 4
|m 7
|o 615.1 BUR
|p A550769B
|r 2022-04-13 00:00:00
|s 2022-03-19
|t 1
|v 109.22
|w 2021-10-31
|x 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons |
|y B
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367186
|a N
|b N
|c nmain
|d 2015-10-29
|g 109.22
|i i13436971
|l 0
|m 0
|o 615.1 BUR
|p A550770B
|r 2015-10-29 00:00:00
|t 1
|v 109.22
|w 2021-10-31
|x 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons |
|y B
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367187
|a N
|b N
|c nmain
|d 2015-10-29
|g 109.22
|i i13436983
|l 2
|m 0
|o 615.1 BUR
|p A550771B
|r 2018-03-13 00:00:00
|s 2018-03-13
|t 1
|v 109.22
|w 2021-10-31
|x 15-12-15 ON RESERVE FOR 527188;24-04-18 OFF RESERVE FOR 527188. CIRCED 3 TIMES |
|y B
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367189
|a N
|b N
|c nmain
|d 2015-10-29
|g 109.22
|i i13437008
|l 3
|m 5
|o 615.1 BUR
|p A550772B
|r 2017-06-14 00:00:00
|s 2017-03-09
|t 1
|v 109.22
|w 2021-10-31
|x 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons |
|y B
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367811
|a N
|b N
|c nmain
|d 2015-10-29
|g 191.14
|i i13443690
|l 2
|m 3
|o 615.1 BUR
|p A556228B
|r 2016-08-24 00:00:00
|s 2016-08-09
|t 1
|v 191.14
|w 2021-10-31
|x 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons |
|y B
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_BUR
|7 0
|9 367976
|a S
|b S
|c smain
|d 2015-10-29
|g 214.30
|i i13445455
|l 4
|m 2
|o 615.1 BUR
|p A556213B
|r 2024-01-16 00:00:00
|s 2018-09-11
|t 1
|v 214.30
|w 2021-10-31
|x 27/3/17 DA Main collection item has the z item code 2 to stop this being requested by BONUS+ patrons |
|y B
|
998 |
|
|
|a (2)b
|a (2)n
|a (2)s
|b 06-04-16
|c m
|d a
|e -
|f eng
|g mou
|h 0
|
999 |
|
|
|c 1286754
|d 1286754
|